SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-370935
Filing Date
2015-11-09
Accepted
2015-11-09 06:19:38
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d18527d10q.htm 10-Q 496823
2 EX-31.1 d18527dex311.htm EX-31.1 6744
3 EX-31.2 d18527dex312.htm EX-31.2 6780
4 EX-32 d18527dex32.htm EX-32 4817
  Complete submission text file 0001193125-15-370935.txt   3502131

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnkd-20150930.xml EX-101.INS 405117
6 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20150930.xsd EX-101.SCH 48240
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20150930_cal.xml EX-101.CAL 67081
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20150930_def.xml EX-101.DEF 303358
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20150930_lab.xml EX-101.LAB 359257
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20150930_pre.xml EX-101.PRE 354647
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 151213881
SIC: 2834 Pharmaceutical Preparations